Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Sruthy Varghese"'
Autor:
Evelyn de Groot, Sruthy Varghese, Lin Tan, Barbara Knighton, Mary Sobieski, Nghi Nguyen, Yong Sung Park, Reid Powell, Philip L. Lorenzi, Bin Zheng, Clifford Stephan, Y. N. Vashisht Gopal
Publikováno v:
Cancer & Metabolism, Vol 10, Iss 1, Pp 1-18 (2022)
Abstract Background Primary and posttreatment resistance to BRAFV600 mutation–targeting inhibitors leads to disease relapse in a majority of melanoma patients. In many instances, this resistance is promoted by upregulation of mitochondrial oxidativ
Externí odkaz:
https://doaj.org/article/b8198ca78c77420fbbfe89e1bf6a9d77
Autor:
Virender Kumar, Sonia yadav, Sruthy Varghese, Reena Devi, Davinder Kumar, Naveen Khatri, Gajendra Singh
Publikováno v:
Current Materials Science. 16
Abstract: Biomaterials, a fascinating and highly interdisciplinary field, have become integral to improving modern man's conditions and quality of life. It is done by many health-related problems arising from many sources. The first batch of biomater
Autor:
Y.N. Vashisht Gopal, Weiyi Peng, Jason Roszik, Yared Hailemichael, Jennifer L. McQuade, Andrew L. Mackinnon, Philip L. Lorenzi, Lin Tan, Barbara Knighton, Catherine K. Luo, Grant M. Fischer, Courtney W. Hudgens, Hannah R. Hodges, Leila J. Williams, Snigdha Pramanik, Sruthy Varghese
Supplementary Methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0bc8bdef8d6767b64612e936048845ca
https://doi.org/10.1158/1535-7163.22520512.v1
https://doi.org/10.1158/1535-7163.22520512.v1
Autor:
Y.N. Vashisht Gopal, Weiyi Peng, Jason Roszik, Yared Hailemichael, Jennifer L. McQuade, Andrew L. Mackinnon, Philip L. Lorenzi, Lin Tan, Barbara Knighton, Catherine K. Luo, Grant M. Fischer, Courtney W. Hudgens, Hannah R. Hodges, Leila J. Williams, Snigdha Pramanik, Sruthy Varghese
Supplementary tables
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6792f38fa34d433328eca682e72fea0a
https://doi.org/10.1158/1535-7163.22520509.v1
https://doi.org/10.1158/1535-7163.22520509.v1
Autor:
Y.N. Vashisht Gopal, Weiyi Peng, Jason Roszik, Yared Hailemichael, Jennifer L. McQuade, Andrew L. Mackinnon, Philip L. Lorenzi, Lin Tan, Barbara Knighton, Catherine K. Luo, Grant M. Fischer, Courtney W. Hudgens, Hannah R. Hodges, Leila J. Williams, Snigdha Pramanik, Sruthy Varghese
Immune-checkpoint inhibitors and adoptive tumor-infiltrating lymphocyte (TIL) therapies have profoundly improved the survival of patients with melanoma. However, a majority of patients do not respond to these agents, and many responders experience di
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9898323fc1f4375448cd5638a032e4b2
https://doi.org/10.1158/1535-7163.c.6542659.v1
https://doi.org/10.1158/1535-7163.c.6542659.v1
Autor:
Y.N. Vashisht Gopal, Weiyi Peng, Jason Roszik, Yared Hailemichael, Jennifer L. McQuade, Andrew L. Mackinnon, Philip L. Lorenzi, Lin Tan, Barbara Knighton, Catherine K. Luo, Grant M. Fischer, Courtney W. Hudgens, Hannah R. Hodges, Leila J. Williams, Snigdha Pramanik, Sruthy Varghese
Supplementary figures
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a95416c428b8a080d37331b9067f8b7
https://doi.org/10.1158/1535-7163.22520515.v1
https://doi.org/10.1158/1535-7163.22520515.v1
Autor:
Sruthy Varghese, Varghese, Lisha
— Cross-site scripting is a common attack on online applications that is vulnerable at the application layer. The attacker injects the script and handles malicious scripts for trusted websites. There are various sorts of XSS scripts that can be use
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a9da66a0eced2a83233751a5aab7dfdf
Autor:
Jason Roszik, Yared Hailemichael, Y.N. Vashisht Gopal, Courtney W. Hudgens, Hannah R. Hodges, Weiyi Peng, Jennifer L. McQuade, Barbara Knighton, Catherine K. Luo, Andrew L. Mackinnon, Snigdha Pramanik, Leila Williams, Philip L. Lorenzi, Lin Tan, Sruthy Varghese, Grant M. Fischer
Publikováno v:
Mol Cancer Ther
Immune-checkpoint inhibitors and adoptive tumor-infiltrating lymphocyte (TIL) therapies have profoundly improved the survival of patients with melanoma. However, a majority of patients do not respond to these agents, and many responders experience di
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9cd6a7fb5263a68d9a6e55a903008739
https://europepmc.org/articles/PMC7933078/
https://europepmc.org/articles/PMC7933078/
Autor:
Snigdha Pramanik, Hannah R. Hodges, Leila Williams, Hussein Abdul-Hassan Tawbi, Vashisht Gopal Yennu Nanda, Weiyi Peng, Sruthy Varghese, Rishika Prasad
Publikováno v:
Cancer Research. 80:PR06-PR06
Nearly all metastatic melanoma patients who respond to targeted therapies will relapse with the disease within a year. Although more durable responses are seen with immune therapies, about half of the melanoma patients do not respond to them, and a s
Publikováno v:
International Journal of Advances in Nursing Management. 4:289